These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6668360)
1. Production of a high affinity antibody specific to the calcium-free-form of calmodulin, using N-acetyl-muramyl-L-alanyl-D-isoglutamine-calmodulin conjugate. Slaninová J; Thorn NA J Immunoassay; 1983; 4(4):395-406. PubMed ID: 6668360 [TBL] [Abstract][Full Text] [Related]
2. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
3. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine). Mozes E; Sela M; Chedid L Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530 [TBL] [Abstract][Full Text] [Related]
4. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide. Phillips NC; Rioux J; Tsao MS Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the antigenic relationship of various derivatives of n-acetyl-muramyl-l-ala-d-isoglutamine (MDP), using anti-MDP antibodies. Bahr GM; Carelli C; Audibert F; Modabber F; Chedid L Mol Immunol; 1982 May; 19(5):737-45. PubMed ID: 7110143 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide. Durette PL; Dorn CP; Friedman A; Schlabach A J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480 [TBL] [Abstract][Full Text] [Related]
7. Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats. Kohashi O; Pearson CM; Tamaoki N; Tanaka A; Shimamura K; Ozawa A; Kotani S; Saito M; Hioki K Infect Immun; 1981 Feb; 31(2):758-66. PubMed ID: 7012019 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a calmodulin antiserum by its reactions with fragments of the calmodulin molecule. Slaninová J; Brzeska H; Thorn NA J Immunoassay; 1986; 7(3):199-207. PubMed ID: 2427545 [TBL] [Abstract][Full Text] [Related]
10. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine. Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635 [TBL] [Abstract][Full Text] [Related]
11. Production of antibodies to calmodulin in rabbits and enzyme immunoassays for calmodulin and anti-calmodulin. Kitajima S; Seto-Ohshima A; Sano M; Kato K J Biochem; 1983 Aug; 94(2):559-64. PubMed ID: 6355079 [TBL] [Abstract][Full Text] [Related]
12. Calmodulin. Production of an antibody in rabbit and development of a radioimmunoassay. Wallace RW; Cheung WY J Biol Chem; 1979 Jul; 254(14):6564-71. PubMed ID: 447735 [TBL] [Abstract][Full Text] [Related]
13. Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells. Chen D; Duggan C; Reden TB; Kooragayala LM; Texada DE; Langford MP Biochemistry; 2004 Sep; 43(37):11796-801. PubMed ID: 15362864 [TBL] [Abstract][Full Text] [Related]
14. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies. Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793 [TBL] [Abstract][Full Text] [Related]
15. Lack of immunostimulatory effect of N-acetyl muramyl-L-alanyl-D-isoglutamine on selected chicken immune functions. Neumann U; Wischner H; Siegmann O Comp Immunol Microbiol Infect Dis; 1982; 5(4):413-21. PubMed ID: 7172620 [TBL] [Abstract][Full Text] [Related]
16. Syntheses of polymeric vesicles containing partial structures of N-acetyl-muramyl-dipeptide (MDP). Hönig H; Zenk R Chem Phys Lipids; 1990 Mar; 53(4):347-56. PubMed ID: 2340605 [TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Leclerc C; Juy D; Bourgeois E; Chedid L Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275 [No Abstract] [Full Text] [Related]
18. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP). Zídek Z; Kameníková L; Buchar E; Janků I; Masek K Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168 [TBL] [Abstract][Full Text] [Related]
19. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions. Souvannavong V; Adam A Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Ogawa T; Kotani S; Shimauchi H Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]